Evaluation of terpenes rich hura crepitans extract on glucose regulation and diabetic complications in stz-induced diabetic rats

Simple item page
dc.contributor.authorLukman, Halimat Yusuf
dc.contributor.authorFadaka, Adewale Oluwaseun
dc.contributor.authorKuo, Yucheng
dc.date.accessioned2024-11-12T07:56:41Z
dc.date.available2024-11-12T07:56:41Z
dc.date.issued2024-08-23
dc.description.abstractThe continual increase in global diabetic statistics portends decreased productivity and life spans, thus making it a disease of concern requiring more effective and safe therapeutic options. While several reports on antidiabetic plants, including Hura crepitans, are available, there is still a dearth of information on the holistic antidiabetic properties of H. crepitans and its associated complications. This study evaluated the antidiabetic potential of methanolic extract of Hura crepitans using in vitro, in vivo, and in silico approaches. The extract revealed a dosedependent in vitro effect, with a 47.97 % and 65.34 % decrease in the fasting blood sugar levels of streptozotocin (STZ) induced diabetic rats at 150 and 300 mg/kg BW, respectively. Likewise, the extract increased serum and pancreatic insulin levels, and significantly ameliorated neuronal oxidative stress and inflammation by reducing the expression levels of cholinesterase, NF-κB, and COX-2 in the brain of hyperglycemic rats. Serum dyslipidemia, liver, and kidney biomarker indices, and hematological alterations in diabetic rats were also significantly attenuated by the extract. Several constituents, mainly terpenes, were identified in the extract. To further predict the drug-likeness, pharmacokinetics, and binding properties of the compounds, in silico analysis was conducted. Ergosta-2,24-dien-26-oicacid,18-(acetyloxy)-5,6-epoxy-4, 22-dihydroxy-1-oxo-,delta.-lactone-4.beta., displayed the highest docking scores for acetylcholinesterase, butyrylcholinesterases, alpha-amylase, and nuclear factor-kB with values of − 12.4, − 10.9, − 10.3, and − 9.4 kcal/mol, while ergost-25-ene-6,12-dione,3,5-dihydroxy-, (3. beta.,5.alpha.) topped for cyclooxygenase-2 (-9.0 kcal/mol). The top-ranked compounds also presented significant oral drug-likeness, pharmacokinetics, and safety properties. Altogether, our data provide preclinical evidence of the potential of Hura crepitans in ameliorating diabetes and its associated complications.
dc.identifier.citationLukman, H.Y., Kuo, Y., Owolabi, M.S., Lawal, B., Chen, L.C., Ajenifujah, O.T., Fadaka, A.O., Olawale, F., Onikanni, S.A., Sani, S. and De Waard, M., 2024. Evaluation of terpenes rich Hura crepitans extract on glucose regulation and diabetic complications in STZ-induced diabetic rats. Biomedicine & Pharmacotherapy, 179, p.117308.
dc.identifier.urihttps://doi.org/10.1016/j.biopha.2024.117308
dc.identifier.urihttps://hdl.handle.net/10566/19642
dc.language.isoen
dc.publisherElsevier Masson s.r.l.
dc.subjectHura crepitans
dc.subjectStreptozotocin
dc.subjectOxidative stress
dc.subjectInflammation
dc.subjectBioactive compounds
dc.titleEvaluation of terpenes rich hura crepitans extract on glucose regulation and diabetic complications in stz-induced diabetic rats
dc.typeArticle

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
lukman_ evaluation of terpenes rich hura_2024.pdf
Size:
15.75 MB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Research Articles (Biotechnology)